2020
DOI: 10.3390/molecules25133083
|View full text |Cite
|
Sign up to set email alerts
|

Thiabendazole and Thiabendazole-Formic Acid Solvate: A Computational, Crystallographic, Spectroscopic and Thermal Study

Abstract: Thiabendazole (TBZ) is a substance which has been receiving multiple important applications in several domains, from medicine and pharmaceutical sciences, to agriculture and food industry. Here, a comprehensive multi-technique investigation on the molecular and crystal properties of TBZ is reported. In addition, a new solvate of the compound is described and characterized structurally, vibrationally and thermochemically for the first time. Density functional theory (DFT) calculations were used to inves… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 43 publications
0
2
0
Order By: Relevance
“…Three thermodynamic and correlating models including modified Apelblat model, λ h model, and NRTL model were chosen to correlate the solubility of TBZ in 12 pure solvents from 283.15 to 323.15 K. The melting point of TBZ is about 573.85 K, and the enthalpy of fusion is about 35.19 kJ/mol based on published data. …”
Section: Resultsmentioning
confidence: 99%
“…Three thermodynamic and correlating models including modified Apelblat model, λ h model, and NRTL model were chosen to correlate the solubility of TBZ in 12 pure solvents from 283.15 to 323.15 K. The melting point of TBZ is about 573.85 K, and the enthalpy of fusion is about 35.19 kJ/mol based on published data. …”
Section: Resultsmentioning
confidence: 99%
“…In the series, we also tested the antiproliferative activities against parasites of new benzimidazole salt formulations, recently licensed by some of us, which demonstrated improved bioavailability and solubility in vivo, in studies against secondary cystic echinococcosis using experimentally infected mice [24]. Remarkably, these patented salts were prepared to overcome the issues related to the poor aqueous solubility of the benzimidazole scaffold and the corresponding erratic bioavailability, as previously explored also by other authors through several strategies, including the inclusion in cyclodextrin complexes [25,26], the transformation into soluble prodrugs [27], the characterization and use of selected polymorphic forms and solvates [28], and the preparation of innovative formulations [29]. In addition to testing antiproliferative activities, we also predicted physico-chemical properties and putative molecular targets for our series of benzimidazoles, using an in silico approach, to further explore the polypharmacology of these compounds.…”
Section: Introductionmentioning
confidence: 99%